000923757 000__ 05418cam\a2200469Ia\4500
000923757 001__ 923757
000923757 005__ 20230306150947.0
000923757 006__ m\\\\\o\\d\\\\\\\\
000923757 007__ cr\un\nnnunnun
000923757 008__ 191214s2020\\\\sz\\\\\\o\\\\\000\0\eng\d
000923757 020__ $$a3030272648
000923757 020__ $$a9783030272647$$q(electronic book)
000923757 020__ $$z9783030272630
000923757 035__ $$aSP(OCoLC)on1130003778
000923757 035__ $$aSP(OCoLC)1130003778
000923757 040__ $$aEBLCP$$beng$$cEBLCP$$dGW5XE$$dESU$$dOCLCF$$dN$T$$dYDX
000923757 049__ $$aISEA
000923757 050_4 $$aTA164
000923757 050_4 $$aTA1-2040
000923757 08204 $$a660.6$$223
000923757 24500 $$aSynthetic Biology 2020 :$$bfrontiers in risk analysis and governance /$$cBenjamin D. Trump, Christopher L. Cummings, Jennifer Kuzma, Igor Linkov, editors.
000923757 260__ $$aCham :$$bSpringer,$$c2020.
000923757 300__ $$a1 online resource (434 pages).
000923757 336__ $$atext$$btxt$$2rdacontent
000923757 337__ $$acomputer$$bc$$2rdamedia
000923757 338__ $$aonline resource$$bcr$$2rdacarrier
000923757 4901_ $$aRisk, Systems and Decisions
000923757 5050_ $$aPreface -- Introduction to Synthetic Biology Risk Governance and Practice -- Section 1: Communities of Practice -- 2: History of Synthetic Biology Research and Scientific Practice -- 3: DIY Community, Biosafety, and Codes of Conduct -- 4: SynBio Research Labs in the Army Corps of Engineers -- Section 2: Examples of Scientific Practice -- 5: Research and Applications of Gene Drive Technology -- 6: Synthetic Biology, Digital Technologies, and Biohacking -- 7: Synthetic Biology experimental research -- biomimicry -- 8: Biosafety Research for SynBio Applications in USACE Labs -- Section 3: Risk Analysis Tools -- 9: Applications of Bayesian Networks to identify SB research needs and uncertainties -- 10: Societal Risk Evaluation Scheme: Early Screening and Prioritizing for Anticipatory Risk Governance -- 11: Synbio -- decision tools to drive governance and decision making -- 12: Challenges of SynBio Risk Management in LCA and other fields -- 13: Methods for Predicting Exposures to Products and Byproducts of Synthetic Biology -- 14: Solution-focused risk assessment for synthetic biology applications -- Section 4: Regulation and Governance -- 15: Comparative Analysis of Regulatory Variations for SynBio -- Applications of Risk Culture -- 16: Adaptive & Anticipatory Governance -- 17: Synbio Regulatory lag and pacing problems -- 18: Synthetic biology governance via existing and prospective legal instruments (tentative) -- Section 5: Risk Communication and Engagement -- 19: Risk Communication, Gene Drives, and the Zika Virus -- 20: Engagement with publics under uncertainty -- 21: Inclusion and Public Engagement in Synthetic Biology: A component of Responsible Innovation -- 22: Biotethical Implications of Synthetic Biology and Emerging -- 23: Discussion/Conclusion.
000923757 506__ $$aAccess limited to authorized users.
000923757 520__ $$aSynthetic biology offers powerful remedies for some of the world's most intractable problems, but these solutions are clouded by uncertainty and risk that few strategies are available to address. The incentives for continued development of this emerging technology are prodigious and obvious, and the public deserves assurances that all potential downsides are duly considered and minimized accordingly. Incorporating social science analysis within the innovation process may impose constraints, but its simultaneous support in making the end products more acceptable to society at large should be considered a worthy trade-off. Contributing authors in this volume represent diverse perspectives related to synthetic biology's social sciences, and reflect on different areas of risk analysis and governance that have developed for the field. Such perspectives include leading scholarly discussion pertaining to risk assessment, governance, ethics, and communication. The chapters of this volume note that while the first twenty years of synthetic biology development have focused strongly on technological innovation and product development, the next twenty should emphasize the synergy between developers, policymakers, and publics to generate the most beneficial, well governed, and transparent technologies and products possible. Many chapters in this volume provide new data and approaches that demonstrate the feasibility for multi-stakeholder efforts involving policymakers, regulators, industrial developers, workers, experts, and societal representatives to share responsibilities in the production of effective and acceptable governance in the face of uncertain risk probabilities. A full consideration of such perspectives may prevent a world of draconian regulations based on an insufficient or incomplete understanding of the science that underpins synthetic biology, as well as any hesitancy or fear by the public to adopt its eventual products.
000923757 588__ $$aDescription based on print version record.
000923757 650_0 $$aSynthetic biology.
000923757 7001_ $$aTrump, Benjamin D.
000923757 7001_ $$aCummings, Christopher L.
000923757 7001_ $$aKuzma, Jennifer.
000923757 7001_ $$aLinkov, Igor.
000923757 77608 $$iPrint version:$$aTrump, Benjamin D.$$tSynthetic Biology 2020: Frontiers in Risk Analysis and Governance$$dCham : Springer,c2020$$z9783030272630
000923757 830_0 $$aRisk, systems and decisions (Series)
000923757 852__ $$bebk
000923757 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-030-27264-7$$zOnline Access$$91397441.1
000923757 909CO $$ooai:library.usi.edu:923757$$pGLOBAL_SET
000923757 980__ $$aEBOOK
000923757 980__ $$aBIB
000923757 982__ $$aEbook
000923757 983__ $$aOnline
000923757 994__ $$a92$$bISE